US FDA clearance to Zimmer Biomet’s ROSA Shoulder System for robotic-assisted shoulder replacement surgery

Zimmer Biomet Holdings, Inc., a global medical technology leader, has gained FDA clearance for its ROSA Shoulder System, marking it as the world's premier robotic surgery system for shoulder replacement. This addition to Zimmer Biomet's ROSA Robotics portfolio, including the ROSA Knee and ROSA Hip Systems, enhances its innovative offerings in shoulder implants and digital technologies.

CEO Ivan Tornos expressed pride in leading the way with robotic surgical assistance for shoulder replacement. ROSA Shoulder empowers surgeons with robotics and data analytics, enabling precise and efficient procedures. It offers flexibility for both anatomic and reverse techniques, ensuring accurate placement and replicating humeral head resectioning without needing a central pin.

Integrated with the Signature ONE Surgical Planning System 2.0, ROSA Shoulder provides pre-operative visualization and creates patient-specific guides. During surgery, it offers real-time data, aiming to reduce complications. Commercial availability in the US is expected in late 2024, with integration into the mymobility Digital Care Management Platform, further enhancing patient care.